Topoisomerase II{alpha} Gene Amplification Predicts Favorable Treatment Response to Tailored and Dose-Escalated Anthracycline-Based Adjuvant Chemotherapy in HER-2/neu-Amplified Breast Cancer: Scandinavian Breast Group Trial 9401.

Research output: Contribution to journalArticle

Details

Authors
  • Minna Tanner
  • Jorma Isola
  • Tom Wiklund
  • Bjorn Erikstein
  • Pirkko Kellokumpu-Lehtinen
  • Per Malmström
  • Nils Wilking
  • Jonas Nilsson
  • Jonas Bergh
Organisations
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Cancer and Oncology
Original languageEnglish
Pages (from-to)2428-2436
JournalJournal of Clinical Oncology
Volume24
Issue number16
Publication statusPublished - 2006
Publication categoryResearch
Peer-reviewedYes